Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range.

Children with Type 1 diabetes will now have access to the Medtronic MiniMed 670G, a hybrid closed-loop system insulin delivery system, following the FDA’s decision to expand the product approval for a ...

The Food and Drug Administration's approval of a new insulin delivery system for people with Type 1 diabetes is a big deal. With Type 1 diabetes, the pancreas makes little or no insulin so people have ...

Medtronic plc.'s MDT Diabetes Management segment is dominating the headlines of late. Following the company’s receipt of the CE Mark approval for its advanced continuous glucose monitoring (CGM) ...

DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...

The U.S. Food and Drug Administration today approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and ...

The MiniMed 780G system has been approved for children aged 7 years and up with type 1 diabetes (T1D), according to Medtronic. The FDA has approved Medtronic’s MiniMed 780G system with Guardian 4 ...

The MiniMed 780G system (Medtronic) advanced hybrid closed-loop insulin delivery system aimed at simplifying the management of type 1 diabetes is now available in the UK for people aged 7 to 80 years.

Medtronic's next-generation automated insulin delivery system, the MiniMed 780G, has received a CE mark for the treatment of type 1 diabetes in people aged 7 to 80 years, which means it can be ...

DUBLIN, June 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Marking of its MiniMed™ 780G system, a next ...

A first-of-its-kind meta-analysis comparing multiple automated insulin delivery (AID) systems in people with type 1 diabetes has found that Medtronic's MiniMed 780G achieved the highest time in target ...